Imaging News

Neurohormonal therapies for the prevention of cardiotoxicity in patients who received chemotherapy conferred improvements in left ventricular ejection fraction as well as left ventricular strain, but benefits were minor and may be within inter-test variability of measurement, researchers reported.

PHILADELPHIA — Right ventricular enlargement, left ventricular hypertrophy and elevated left- and right-sided pressures were among the predictors of HF hospitalization or CV death among patients with HF with preserved ejection fraction, according to data from the PARAGON-HF echocardiographic substudy.

Using diffusion tensor imaging segmentation, an advanced MRI brain scan analysis, researchers were able to assess microstructural brain damage to predict dementia in patients with cerebral small vessel disease and lacunar strokes.

PARIS — In patients with transient STEMI, defined as those who present with STEMI but have their ST-segment elevation and symptoms completely resolve before revascularization, immediate revascularization led to similar outcomes as delayed revascularization, according to data from the TRANSIENT trial.

PARIS — Defining global longitudinal strain variance in a normal patient population may be used as a clinical decision-making tool to aid the clinician in the detection of myocardial dysfunction, according to a patient meta-analysis presented at the European Society of Cardiology Congress.

Cardiac MRI can be a technology that can help cardiologists to characterize myocardial tissue, particularly in patients who had a reperfused MI. A recent scientific expert panel was published in the Journal of the American College of Cardiology that provides recommendations on how best to utilize this technology when selecting endpoints for future clinical and experimental trials.

The American Heart Association released a scientific statement outlining the options for perfusion assessment in patients with critical limb ischemia.

Comparison of MR perfusion imaging to coronary angiography to measure fractional flow reserve in patients with stable chest pain.

The FDA today issued a series of recommendations following an advisory panel meeting on a signal of late mortality risk associated with paclitaxel-coated devices to treat peripheral artery disease, including advising clinicians to discuss extensively with patients the risks and benefits of the devices and to ensure patients are on optimal medical therapy and are following appropriate lifestyle practices.

Among patients with idiopathic pulmonary fibrosis, the effects of nintedanib plus sildenafil, as compared with nintedanib alone, on quality of life and FVC did not differ significantly between patients with and those without evidence of right heart dysfunction, according to subgroup analyses of the INSTAGE trial.